Unlearn.AI is an AI platform designed to streamline clinical research. It creates patient “digital twins” from historical patient data, then uses these models to predict treatment outcomes and support faster drug development. The approach can reduce study costs and shorten timelines by lowering the number of participants needed in control groups.
Key capabilities
- Build digital twins of patients from historical datasets
- Predict clinical outcomes and treatment response
- Optimize clinical trial design and planning
- Reduce trial duration and overall cost
- Decrease the size of control groups
How it works
- Upload historical patient data
- The system generates digital twin models based on the dataset
- Models forecast how patients are likely to respond to treatment
- Use the results to plan and run clinical studies
Notes and fit
- Requires high-quality historical patient data
- Working with digital twins may be complex for first-time users
- Best suited for pharmaceutical companies and medical research centers
